Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

403
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
403
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

232
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
232
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

306
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
306
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

176
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
176
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

678
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
678
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

200
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
200

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of Visfatin Concentration and Other Potential Biomarkers Associated with MASLD Development in Saliva and Serum of Patients with Obesity-A Pilot Study.

Nutrients·2026
Same author

Heat-Not-Burn Tobacco Aerosols Induce Immune Dysregulation and Barrier Disruption Comparable to Conventional Cigarettes.

Allergy·2025
Same author

The Impact of Environmental Factors on the Secretion of Gastrointestinal Hormones.

Nutrients·2025
Same author

Could Selected Adipokines/Cytokines Serve as Markers of Adipose Tissue Dysfunction?

International journal of molecular sciences·2025
Same author

The Impact of Gastrointestinal Hormones on Human Adipose Tissue Function.

Nutrients·2024
Same author

Estimation of the Impact of Abdominal Adipose Tissue (Subcutaneous and Visceral) on the Occurrence of Carbohydrate and Lipid Metabolism Disorders in Patients with Obesity-A Pilot Study.

Nutrients·2024

Related Experiment Video

Updated: Sep 6, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.4K

Nutrition and Supplementation in Ulcerative Colitis.

Marcelina Radziszewska1, Joanna Smarkusz-Zarzecka1, Lucyna Ostrowska1

  • 1Department of Dietetics and Clinical Nutrition, Medical University of Bialystok, Ul. Mieszka I 4B, 15-054 Bialystok, Poland.

Nutrients
|June 24, 2022
PubMed
Summary

Dietary changes and supplements can impact ulcerative colitis (UC), an inflammatory bowel disease. The Mediterranean diet shows promise, but further research is needed for newer plans like the UC Exclusion Diet.

Keywords:
FODMAPMediterranean dietSCDUCEDcolitis ulcerosadietsupplementsulcerative colitis

More Related Videos

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

47.8K
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

301

Related Experiment Videos

Last Updated: Sep 6, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.4K
DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

47.8K
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

301

Area of Science:

  • Gastroenterology
  • Nutritional Science
  • Microbiome Research

Background:

  • Ulcerative colitis (UC) is a chronic, incurable inflammatory bowel disease (IBD) affecting the colon.
  • UC is characterized by periods of remission and exacerbation, significantly impacting patients' quality of life.
  • The gut microbiome plays a crucial role in IBD pathogenesis and progression.

Purpose of the Study:

  • To review current scientific literature on the impact of various dietary plans and supplements on ulcerative colitis.
  • To identify evidence-based nutritional strategies for managing UC.
  • To assess the role of diet and supplementation in modulating the gut microbiome in UC patients.

Main Methods:

  • Systematic review of 98 recent scientific articles focusing on nutrition and supplementation in ulcerative colitis.
  • Analysis of studies investigating the effects of different diets and specific nutrients on UC course.
  • Evaluation of research on the influence of dietary components on gut microbiome composition and function.

Main Results:

  • The Mediterranean diet demonstrates significant promise in managing UC due to its rich content of bioactive compounds.
  • The UC Exclusion Diet (UCED) may offer benefits, but requires further investigation as a novel dietary approach.
  • Unconventional, restrictive diets can negatively affect the nutritional status and overall health of UC patients.
  • Omega-3 fatty acids and probiotics show potential therapeutic benefits, though evidence remains inconclusive.

Conclusions:

  • Dietary interventions, including the Mediterranean diet, are important therapeutic considerations for ulcerative colitis management.
  • Further research is essential to validate the efficacy and safety of newer dietary plans like UCED.
  • Careful consideration of diet and supplementation is crucial to optimize gut health and potentially improve outcomes in IBD.
  • While promising, the role of specific supplements like omega-3s and probiotics requires more robust evidence.